A multimodal fusion system predicting survival benefits of immune checkpoint inhibitors in unresectable hepatocellular carcinoma
2025 · npj Precision Oncology · 6 citations
https://doi.org/10.1038/s41698-025-00979-6
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Jun Xu is an academic researcher.
ORCID: 0009-0003-2007-7865Click to start Chat